Posts tagged Codexis
HCW starts Codexis at buy

H.C. Wainwright has launched coverage of Codexis (NASDAQ:CDXS) with a “buy” rating and $6 price target. The stock closed at $4.23 on Tuesday.

Codexis is a biotechnology services company that specializes in the development of novel, high-efficiency biocatalysts used in manufacturing processes.

Read More